XOMA (US) LLC

Type: Company
Name: XOMA (US) LLC
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Your September Biotech Back-to-School Calendar

08/26/14 - 09:50 AM EDTBOSTON ( TheStreet ) -- If you're like me, a dad with school-age kids, September is a real page turner in the calendar. Everyone gets a fresh start on January 1, but Labor Day serves the same purpose. The lazy days of summer are ... [Published TheStreet.com - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 1 reports

When companies flee US tax system, investors often don’t reap big returns

in World Economy News 25/08/2014Establishing a tax domicile abroad to avoid U.S. taxes is a hot strategy in corporate America, but many companies that have done such “inversion” deals have failed to produce above-average returns for investors, a Reuters ... [Published Hellenic Shipping News Worldwide - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

XOMA Q2 net loss decreases

(MarketLine via COMTEX News Network) -- XOMA Corporation, a developer of antibody-based therapeutics, has reported that net loss for the second quarter ended June 30, 2014 was $11.9 million, or $0.17 loss per diluted share, compared to a net loss of $17.25 ... [Published PredictWallStreet - Aug 25 2014]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

Companies fleeing US tax system not reaping big returns for investors

Establishing a tax domicile abroad to avoid US taxes is a hot strategy in corporate America, but many companies that have done such “inversion” deals have failed to produce above-average returns for investors, a Reuters analysis has found.Looking back ... [Published Times of Malta - Aug 23 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Insider Selling: Paul D. Rubin Sells 26,748 Shares of XOMA Corp Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) CMO Paul D. Rubin sold 26,748 shares of the stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $4.34, for a total transaction of $116,086.32. Following the completion of the sale, the ... [Published American Banking News - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 2 reports

Insider Selling: XOMA Corp CMO Unloads 26,748 Shares of Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) CMO Paul D. Rubin sold 26,748 shares of XOMA Corp stock on the open market in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $4.34, for a total value of $116,086.32. Following the ... [Published Mideast Time - Aug 19 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 2 reports

The Bottom Line To Investors From Tax Inversions: No Above Average Returns

While it remains to be seen if Obama can put an end to what has been the hottest M&A trend in 2014, namely engaging in tax redomiciling "inversion" deals, it is clear that the C-suite is delighted to continue pursuing deals which minimize the cash outflows ... [Published Zero Hedge - Aug 18 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Big call spread detected in Xoma

A call calendar spread tops the option trade in antibody-based therapeutic company Xoma.optionMONSTER's tracking systems show the sale of 2,000 September 5 calls for $0.30 against open interest of 7,644. An equal number of March 5 calls were bought at ... [Published Option Monster - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

5 Stocks Ready for Breakouts

DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes out a prior overhead resistance point, then it's free to find new buyers and momentum players who can ... [Published The Street Latest - Aug 11 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 2 reports

MLV & Co Has Positive Outlook On XOMA

In a report published Friday, MLV & Co analyst George B. Zavoico reiterated a Buy rating and $7.00 price target on XOMA (NASDAQ: XOMA).In the report, MLV & Co noted, “Yesterday afternoon, after markets closed, XOMA Corp. reported 2Q:14 results and updated ... [Published Benzinga.com - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

XOMA Corp (XOMA) Set to Announce Earnings on Thursday

XOMA Corp (NASDAQ:XOMA) is scheduled to release its Q214 earnings data on Thursday, August 7th. Analysts expect XOMA Corp to post earnings of ($0.21) per share and revenue of $5.32 million for the quarter. Persons that are interested in participating ... [Published American Banking News - Aug 06 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 2 reports

XOMA Corp VP Unloads $19,150 in Stock (XOMA)

XOMA Corp (NASDAQ:XOMA) VP Patrick J. Md Phd Scannon sold 5,000 shares of XOMA Corp stock on the open market in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $3.83, for a total value of $19,150.00. Following ... [Published American Banking News - Aug 05 2014]

Quotes

John Varian, CEO of XOMA, commented, "Our primary focus is driving gevokizumab towards its first Biologics Licensing Application (BLA), which is reflected in our second quarter 2014 activities. Upon receipt of successful results from the EYEGUARD-B study, we intend to request a pre-BLA meeting with the FDA. Statistically significant and clinically meaningful data from the Phase 3 study and the data generated from the two Phase 2 trials in Behcet's disease patients with non-infectious uveitis could support a BLA filing in Behcet's disease uveitis."
...But what is the track record of tax inversions when it comes to the bottom line, namely investor returns.  According to a Reuters calculation , "companies that have done such "inversion" deals have failed to produce above-average returns for investors ."
...It recovered and so did its stock price, but the 2008 economic downturn, he said, brought "an extended period of moderate demand and intense competitive pressure. These conditions have adversely affected the performance of all of the companies in this sector."
...may be available as advancements in life sciences continue to develop at a swift pace," said Mark Benson, Director of Research, Wedbush Securities. "Our conference will address these issues and provide critical insights through sector specific deep dives, moderated management presentations, one-on-one meetings and informative panels comprised of industry experts."

More Content

All (53) | News (38) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (1) | Press Releases (11)
sort by: Date | Relevance
Effect of Darapladib on Major Coronary Events A... [Published Journal of the American Medical Association - Aug 31 2014]
Your September Biotech Back-to-School Calendar [Published TheStreet.com - Aug 26 2014]
XOMA Q2 net loss decreases [Published PredictWallStreet - Aug 25 2014]
When companies flee US tax system, investors of... [Published Hellenic Shipping News Worldwide - Aug 25 2014]
Companies fleeing US tax system not reaping big... [Published Times of Malta - Aug 23 2014]
Insider Selling: Paul D. Rubin Sells 26,748 Sha... [Published American Banking News - Aug 21 2014]
Insider Selling: XOMA Corp CMO Unloads 26,748 S... [Published Mideast Time - Aug 19 2014]
XOMA Corp VP Unloads $25,304 in Stock (XOMA) [Published American Banking News - Aug 19 2014]
The Bottom Line To Investors From Tax Inversion... [Published Zero Hedge - Aug 18 2014]
The Bottom Line To Investors From Tax Inversion... [Published Zero Hedge - Aug 18 2014]
INSIGHT-When companies flee US tax system, inve... [Published London South East - Aug 18 2014]
Biotech investment has increased significantly ... [Published Live-PR.com - Aug 13 2014]
Wedbush PacGrow Life Sciences Hosts Management ... [Published Nations Restaurant News - Aug 12 2014]
Big call spread detected in Xoma [Published Option Monster - Aug 12 2014]
Ekhaya and Light House put housing crisis in pe... [Published BDlive - Aug 12 2014]
5 Stocks Ready for Breakouts [Published The Street Latest - Aug 11 2014]
MLV & Co Has Positive Outlook On XOMA [Published Benzinga.com - Aug 08 2014]
XOMA Corp (XOMA) Releases Quarterly Earnings, B... [Published American Banking News - Earnings - Aug 08 2014]
Wall Street Breakfast: BofA Closes In On $16B-$... [Published Seeking Alpha - Aug 07 2014]
Kalorama Issues Biotech Funding Deals and Partn... [Published Individual.com - Aug 07 2014]
XOMA to Present at Two Upcoming Investor Confer... [Published GlobeNewswire: Advertising News - Aug 06 2014]
Relative Success Rates by Drug Class: The Case ... [Published American Pharmaceutical Outsourcing - Aug 06 2014]
Global Uveitis market will grow at 26.46% CAGR ... [Published Live-PR.com - Aug 06 2014]
Global Type 1 Diabetes Market will grow at 6.9%... [Published Live-PR.com - Aug 06 2014]
XOMA Corp (XOMA) Set to Announce Earnings on Th... [Published American Banking News - Aug 06 2014]
XOMA Corp VP Unloads $19,150 in Stock (XOMA) [Published American Banking News - Aug 05 2014]
Insider Selling: XOMA Corp VP Unloads 5,000 Sha... [Published American Banking News - Aug 05 2014]
Kalorama: Yellen Comments on Biotechnology Sect... [Published Digital Journal - Aug 04 2014]
XOMA to Announce Second Quarter 2014 Financial ... [Published GlobeNewswire: Advertising News - Jul 30 2014]
Apple cored: business as usual at UH [Published The Hawaii Independent - Jul 29 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Bottom Line To Investors From Tax Inversion... [Published Zero Hedge - Aug 18 2014]
While it remains to be seen if Obama can put an end to what has been the hottest M&A trend in 2014, namely engaging in tax redomiciling "inversion" deals, it is clear that the C-suite is delighted to continue pursuing deals which minimize the cash outflows ...
BioInvent Interim Report 1 January – 30 June 2014 [Published CisionWire - English - Jul 24 2014]
Milestone payments and sale of product rights bring profit in second quarterSecond quarter 2014, April - June· Net sales for April – June 2014 amounted to SEK 32 (12) million.· Earnings after tax for April – June 2014: SEK 3.7 (-9.4) million.· Earnings ...
XOMA Suffers Big Setback [Published Wall St. Cheat Sheet - Mar 05 2014]
While many biotechnology stocks have been generating impressive returns of late, one stock suffered a major setback on Tuesday evening. That company is XOMA Corporation ( NASDAQ:XOMA ). XOMA Corporation is a biotechnology company focused on the ...
1

Press Releases

sort by: Date | Relevance
XOMA to Present at Two Upcoming Investor Confer... [Published GlobeNewswire: Advertising News - Aug 06 2014]
XOMA to Announce Second Quarter 2014 Financial ... [Published GlobeNewswire: Advertising News - Jul 30 2014]
Pre-market Equity Watch on Biotech Industry -- ... [Published Financial Services - Jul 10 2014]
XOMA Call Today at 4:30pm ET/1:30pm PT to Confi... [Published GlobeNewswire: Acquisitions News - Jun 30 2014]
Health Care Sector Stocks Highlight -- Research... [Published Financial Services - Jun 02 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.